| Literature DB >> 14519665 |
Stephan Seeliger1, Cllaudia K Derian, Nathalie Vergnolle, Nigel W Bunnett, Roman Nawroth, Martin Schmelz, Pierre-Yves Von Der Weid, Jörg Buddenkotte, Cord Sunderkötter, Dieter Metze, Patricia Andrade-Gordon, Erik Harms, Dietmar Vestweber, Thomas A Luger, Martin Steinhoff.
Abstract
Proteinase-activated receptor-2 belongs to a new subfamily of G-protein-coupled receptors. Its precise role during inflammation and the underlying mechanisms is still unclear. Our study establishes that PAR-2 plays a direct proinflammatory role during cutaneous inflammation in mice and humans in vivo. In a model of experimentally induced allergic (ACD) and toxic (ICD) contact dermatitis (CD) we show that ear swelling responses, plasma extravasation, and leucocyte adherence were significantly attenuated in PAR-2 null mutant (PAR-2-/-) mice compared with wild-type (PAR-2+/+) mice, especially at early stages. The proinflammatory effects by PAR-2 activation were significantly diminished using nitric oxide-synthase inhibitors, while NF-kappaB and neuropeptides appear to play a minor role in these mechanisms. PAR-2-mediated up-regulation of E-selectin and cell adhesion molecule ICAM-1; enhanced plasma extravasation was observed in humans and mice and of interleukin-6 in mice in vivo. Thus, PAR-2 may be a beneficial therapeutic target for the treatment of inflammatory skin diseases.Entities:
Mesh:
Substances:
Year: 2003 PMID: 14519665 DOI: 10.1096/fj.02-1112com
Source DB: PubMed Journal: FASEB J ISSN: 0892-6638 Impact factor: 5.191